Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
02/23/2011 | EP1697347B1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
02/23/2011 | EP1634589B1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
02/23/2011 | EP1409461B1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
02/23/2011 | CN101981182A Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use therof |
02/23/2011 | CN101981060A Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity |
02/23/2011 | CN101981047A Novel lupane derivatives |
02/23/2011 | CN101981038A Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
02/23/2011 | CN101980721A Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
02/23/2011 | CN101980711A Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
02/23/2011 | CN101980708A 5imidazoquinolines and pyrimidine derivatives as potent modulators of VEGF-driven angiogenic processes |
02/23/2011 | CN101980707A Novel substituted imidazoquinolines |
02/23/2011 | CN101979595A Dual expression vector for immunostimulatory RNA and HBV target gene silence RNA, construction and application thereof |
02/23/2011 | CN101979581A S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof |
02/23/2011 | CN101979566A Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
02/23/2011 | CN101979558A Small interfering RNA (siRNA) molecule of targeted hepatitis B virus (HBV) gene and application thereof |
02/23/2011 | CN101979557A SiRNA molecule and application thereof to antiviral medicaments |
02/23/2011 | CN101979556A Small interfering ribose nucleic acid (siRNA) targeting molecule and application thereof |
02/23/2011 | CN101979555A Small interference RNA molecule and application thereof |
02/23/2011 | CN101979554A siRNA molecule interfering HBV gene and application thereof |
02/23/2011 | CN101979553A siRNA molecule for interfering HBV gene and antiviral application thereof |
02/23/2011 | CN101979552A Structure of targeted hepatitis C virus (HCV)F gene and application of targeted HCVF gene |
02/23/2011 | CN101979519A Method for preparing pseudorabies vaccines |
02/23/2011 | CN101979515A Animal rabies virus and vaccine and production method thereof |
02/23/2011 | CN101979514A Virus and vaccine of porcine reproductive and respiratory syndrome and preparation method of same |
02/23/2011 | CN101979513A Duck-origin paramyxovirus attenuated lapinized Chineses (LC) strain and application thereof to the preparation of vaccines |
02/23/2011 | CN101979504A Yersinia pestis ghost, preparation method thereof, and application of Yersinia pestis ghost serving as vaccine |
02/23/2011 | CN101979503A Recombinant brucella for expressing Asia type-I foot and mouth disease virus VP1 genes and method for producing vaccines thereof |
02/23/2011 | CN101979502A Recombinant brucella expressing VP1 gene of O-type foot-and-mouth disease virus and method for producing vaccines thereof |
02/23/2011 | CN101979501A Recombinant Salmonella choleraesuis for expressing surface antigen gene sao of streptococcus suis type 2, vaccine and application |
02/23/2011 | CN101979494A Flu-preventing kiwi wine and preparation method thereof |
02/23/2011 | CN101979412A IL-18 binding proteins |
02/23/2011 | CN101979405A Immune dominant HLA-A3 super-type restrictive CTL epitope of hepatitis B virus core antigen and identification method and application thereof |
02/23/2011 | CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof |
02/23/2011 | CN101979403A Novel broad caspase inhibitor and preparation method and application thereof |
02/23/2011 | CN101979397A HCV nucleoside inhibitor |
02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
02/23/2011 | CN101979089A Bovine staphylococcus aureus mastitis inactivated vaccine and preparation method thereof |
02/23/2011 | CN101979086A Chinese medicinal preparation for treating dermatophytosis |
02/23/2011 | CN101979070A Chinese medicament for treating hepatitis B |
02/23/2011 | CN101979067A Traditional Chinese medicine for treating gonorrhoea |
02/23/2011 | CN101979055A Medicinal composition for treating fowl pox and preparation method thereof |
02/23/2011 | CN101979048A Medicinal composition of lonicera confusa and preparation method thereof |
02/23/2011 | CN101979023A Chinese medicine for curing chronic hepatitis |
02/23/2011 | CN101978999A Medicament for treating icteric hepatitis |
02/23/2011 | CN101978997A Externally-applied cream for treating wind-heat cold by adopting transdermal absorption technology |
02/23/2011 | CN101978994A Method for judging active ingredients of rhubarb |
02/23/2011 | CN101978977A Self-emulsifying brucea javanica oil oral preparation composition and preparation method thereof |
02/23/2011 | CN101978964A Compound gentamycin sulfate injection for treating swine plague and preparation method thereof |
02/23/2011 | CN101978961A Composition for treating gingivitis or peridentitis and application thereof |
02/23/2011 | CN101978952A Method for preparing berberine hydrochloride liposome preparation |
02/23/2011 | CN101978947A Long-acting Cefquinome sulfate injection and preparation method thereof |
02/23/2011 | CN101978864A Rape bee-pollen extract and use thereof |
02/23/2011 | CN101978852A Microbial feed additive for treating piglet yellow and white dysentery and preparation method thereof |
02/23/2011 | CN101618162B Traditional Chinese medicine for treating viral keratitis |
02/23/2011 | CN101392256B Gene synthesis of wild boar alpha-interferon, vector construction and method for producing outcome |
02/23/2011 | CN101313925B Sanshi detoxication powder |
02/23/2011 | CN101220349B Separated coliphage and application as biological fungicide in foods and anti-infection contamination thereof |
02/22/2011 | USRE42164 Hepatitis C inhibitor tri-peptides |
02/22/2011 | US7894769 Wireless microphone communication system |
02/22/2011 | US7893282 7-substituted fused ring tetracycline compounds |
02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
02/22/2011 | US7893084 Viral polymerase inhibitors |
02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
02/22/2011 | US7893057 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
02/22/2011 | US7893055 HIV integrase inhibitors |
02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
02/22/2011 | US7893027 Treatment of ocular wounds and ulcers |
02/22/2011 | US7892782 Screening process for antibacterial agents |
02/22/2011 | US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
02/22/2011 | US7892574 Topical administration of oxazolidinones for transdermal delivery |
02/22/2011 | US7892556 Apoptotically active peptides |
02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
02/22/2011 | CA2601515C Compounds having immunomodulator activity |
02/22/2011 | CA2553879C Viral polymerase inhibitors |
02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
02/22/2011 | CA2459857C Combinatorial type controlled release drug delivery device |
02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
02/22/2011 | CA2399504C Methods for producing temperature-sensitive morbillivirus |
02/22/2011 | CA2392685C Antisense antibacterial method and composition |
02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
02/22/2011 | CA2223754C Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
02/17/2011 | WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza |
02/17/2011 | WO2011019839A2 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
02/17/2011 | WO2011019405A1 Pyrimidine compounds as tuberculosis inhibitors |
02/17/2011 | WO2011019317A1 Compositions and methods for treating fungal infection of the nail |
02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
02/17/2011 | WO2011018653A2 Treatment of viral infections |
02/17/2011 | WO2011017998A1 Gambogic acid cyclization analogues, preparation method and application thereof |
02/17/2011 | WO2011017799A1 Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions |
02/17/2011 | WO2010146585A4 Tellurium-containing compounds for treating viral infections |
02/17/2011 | WO2010138889A8 Peptides for the treatment of hcv infections |
02/17/2011 | WO2010124097A3 Transcription factor modulating compounds and methods of use thereof |